Axumin PET Scans: A Breakthrough for Prostate Cancer
BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …
P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Radiation is the most common treatment for a local relapse after surgery. While radiation is often effective, the possibility of microscopic metastases outside the prostate fossa needs to be considered since radiation to the fossa alone will fail to be curative if cancer is also present in other parts of the body. The actual presence or absence of microscopic metastasis is never certain since there is no technology capable of detecting them. Microscopic metastases are more likely when the Gleason score is high and when PSA is rising quickly. In these situations, when the likelihood of microscopic metastases is higher, additional radiation to the lymph nodes in combination with testosterone inactivating pharmaceuticals (TIP) should be considered.